Xencor Inc (XNCR)

Add to Watchlists
Create an Alert
36.91 +1.43  +4.03% NASDAQ Sep 20, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/05/2019 16:30 EST Misc Xencor Inc Third Quarter Earnings Conference Call in 2019
11/05/2019 Earnings Xencor Inc Third Quarter Earnings in 2019 Release
08/06/2019 16:30 EDT Misc Xencor Inc Second Quarter Earnings Conference Call in 2019
08/06/2019 Earnings Xencor Inc Second Quarter Earnings in 2019 Release
06/26/2019 13:30 PDT Misc Xencor Inc Annual General Meeting in 2018
05/09/2019 16:30 EDT Misc Xencor Inc First Quarter Earnings Conference Call in 2019
05/09/2019 Earnings Xencor Inc First Quarter Earnings in 2019 Release
02/25/2019 16:30 EST Misc Xencor Inc Fourth Quarter Earnings Conference Call in 2018
02/25/2019 Earnings Xencor Inc Fourth Quarter Earnings in 2018 Release
11/05/2018 16:30 EST Misc Xencor Inc Third Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.xencor.com
  • Investor Relations URL: http://investors.xencor.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 05, 2019
  • Last Earnings Release: Aug. 06, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Xencor Inc is a clinical‑stage bio pharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life‑threatening diseases with unmet medical needs. It uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. Xencor earns its revenue from research and development collaborations and licenses of its internally-developed drug candidates.

Top Fund Holders

Symbol Name Weighting
CNCR Loncar Cancer Immunotherapy ETF 4.45%
PBE Invesco Dynamic Biotech & Genome ETF 2.58%
POAGX PRIMECAP Odyssey Aggressive Growth 1.92%
PSCH Invesco S&P SmallCap Health Care ETF 1.82%
RYWCX Rydex S&P SmallCap 600 Pure Growth C 1.36%
BBC Virtus LifeSci Biotech Clinical Trls ETF 1.21%
RZG Invesco S&P SmallCap 600® Pure Gr ETF 1.16%
WTMIX Segall Bryant & Hamill Micro Cap Retail 1.01%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("XNCR","name")
  • Description: =YCI("XNCR","description")
  • Sector: =YCI("XNCR","sector")
  • Industry: =YCI("XNCR","industry")
  • Est. Current Fiscal Year End: =YCI("XNCR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.